Plant virus incorporated hydrogels as scaffolds for tissue engineering possess low immunogenicity in vivo

Journal of Biomedical Materials Research - Part A

Volumn 103, Issue 3, 2015, Pages 887-895

  Luckanagul, Jittima Amie ^a   Lee, L Andrew ^a   You, Shaojin ^b   Yang, Xiaoming ^c   Wang, Qian ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

^c WJB Dorn VA Medical Center   (United States)

Author keywords

Biocompatibility; Hydrogel; Implant; Tissue engineering; Tobacco mosaic virus; Virus nanoparticles

Indexed keywords

BIOCOMPATIBILITY; BIODEGRADABILITY; IMPLANTS (SURGICAL); SCAFFOLDS (BIOLOGY); STEM CELLS; TISSUE; TISSUE ENGINEERING; TOBACCO; TOXICITY; VIRUSES;

BUILDING BLOCKES; CLINICAL APPLICATION; HYDROGEL IMPLANTS; MATERIAL CHEMISTRY; OSTEOGENIC DIFFERENTIATION; SCAFFOLDING MATERIALS; SCAFFOLDS FOR TISSUE ENGINEERING; TOBACCO MOSAIC VIRUS;

HYDROGELS;

ARGINYLGLYCYLASPARTIC ACID; ALGINIC ACID; ARGINYL-GLYCYL-ASPARTIC ACID; BIOMATERIAL; CAPSID PROTEIN; HYDROGEL; NANOMATERIAL; OLIGOPEPTIDE; PARAFFIN; PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGENICITY; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; BONE DEVELOPMENT; CELL ADHESION; CELL DIFFERENTIATION; CONTROLLED STUDY; HYDROGEL; IMMUNE RESPONSE; IMMUNOGENICITY; IMPLANT; IMPLANTATION; IN VIVO STUDY; MOUSE; NONHUMAN; STEM CELL CULTURE; TISSUE ENGINEERING; TOBACCO MOSAIC VIRUS; TOXICITY ASSAY; ANIMAL; BAGG ALBINO MOUSE; BONE; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; MALE; METABOLISM; MUTATION; PROCEDURES; REGENERATIVE MEDICINE; TISSUE SCAFFOLD;

ALGINATES; ANIMALS; BIOCOMPATIBLE MATERIALS; BONE AND BONES; CAPSID PROTEINS; CELL ADHESION; CELL DIFFERENTIATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HYDROGELS; MALE; MICE; MICE, INBRED BALB C; MUTATION; NANOSTRUCTURES; OLIGOPEPTIDES; OSTEOGENESIS; PARAFFIN; PEPTIDES; REGENERATIVE MEDICINE; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TOBACCO MOSAIC VIRUS;

EID: 84922950046     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.35227     Document Type: Article

References (46)

1. Liu Z, Qiao J, Niu Z., Wang Q. Natural supramolecular building blocks: from virus coat proteins to viral nanoparticles. Chem Soc Rev 2012; 41:6178-6194.
2. Pokorski JK, Steinmetz NF. The art of engineering viral nanoparticles. Mol Pharm 2011; 8:29-43.
3. Chung WJ, Merzlyak A, Yoo S.Y., Lee SW. Genetically engineered iquid-crystalline viral films for directing neural cell growth. Langmuir 2010; 26:9885-9890.
4. Lee LA, Nguyen QL, Wu L, Horvath G., Nelson RS, Wang Q. Mutant plant viruses with cell binding motifs provide differentia adhesion strengths and morphologies. Biomacromolecules 2011; 13:422-431.
5. Merzlyak A, Indrakanti S, Lee SW. Genetically engineered nanofiber-like viruses for tissue regenerating materials. Nano Lett 2009; 9:846-852.
6. Mills CA, Martinez E, Errachid A., Engel E, Funes M, Moormann C., Wahlbrink T, Gomila G, Planell J, Samitier J. Nanoembossed polymer substrates for biomedical surface interaction studies. J Nanosci Nanotechnol 2007; 7:4588-4594.
7. Steinmetz NF. Viral nanoparticles as platforms for next-generation therapeutics and imaging devices. Nanomedicine 2010; 6:634-641.
8. Steinmetz NF. Viral nanoparticles in drug delivery and imaging. Mol Pharm 2013; 10:1-2.
9. Wen AM, Rambhia PH, French R.H., Steinmetz NF. Design rules for nanomedical engineering: from physical virology to the applications of virus-based materials in medicine. J Biol Phys 2013; 39: 301-325.
10. Kaur G, Valarmathi MT, Potts J.D., Jabbari E., Sabo-Attwood T, Wang Q. Regulation of osteogenic differentiation of rat bone marrow stromal cells on 2D nanorod substrates. Biomaterials 2010; 31:1732-1741.
11. Kaur G, Wang C, Sun J., Wang Q. The synergistic effects of multivalent ligand display and nanotopography on osteogenic differentiation of rat bone marrow stem cells. Biomaterials 2010; 31:5813-5824.
12. Lee LA, Muhammad SM, Nguyen Q.L., Sitasuwan P., Horvath G, Wang Q. Multivalent ligand displayed on plant virus induces rapid onset of bone differentiation. Mol Pharm 2012; 9:2121-2125.
13. Sitasuwan P, Lee LA, Bo P, Davis E.N., Lin Y., Wang Q. A plant virus substrate induces early upregulation of BMP2 for rapid bone formation. Integr Biol 2012; 4:651-660.
14. Luckanagul J, Lee LA, Nguyen Q.L., Sitasuwan P., Yang X, Shazly T, Wang Q. Porous alginate hydrogel functionalized with virus as three-dimensional scaffolds for bone differentiation. Biomacromolecules 2012; 13:3949-3958.
15. Kaiser CR, Flenniken ML, Gillitzer E, Harmsen A.L., Harmsen AG, Jutila MA, Douglas T, Young MJ. Biodistribution studies of protein cage nanoparticles demonstrate broad tissue distribution and rapid clearance in vivo. Int J Nanomed 2007; 2:715-733.
16. Lewis JD, Destito G, Zijlstra A., Gonzalez MJ, Quigley JP, Manchester M, Stuhlmann H. Viral nanoparticles as tools for intravital vascular imaging. Nat Med 2006; 12:354-360.
17. Molenaar TJ, Michon I, de Haas SA, van Berkel TJ, Kuiper J, Biessen EA. Uptake and processing of modified bacteriophage M13 in mice: Implications for phage display. Virology 2002; 293: 182-191.
18. Singh P, Prasuhn D, Yeh R.M., Destito G., Rae CS, Osborn K, Finn MG, Manchester M. Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivo. J Control Release 2007; 120:41-50.
19. Wu M, Shi J, Fan D., Zhou Q, Wang F, Niu Z., Huang Y. Biobehavior in normal and tumor-bearing mice of Tobacco mosaic virus. Biomacromolecules 2013; 14:4032-4037.
20. Bruckman MA, Randolph LN, VanMeter A, Hern S., Shoffstall AJ, Taurog RE, Steinmetz NF. Biodistribution, pharmacokinetics, and blood compatibility of native and PEGylated Tobacco mosaic virus nano-rods and -spheres in mice. Virology 2014; 449:163-173.
21. Manchester M, Singh P. Virus-based nanoparticles (VNPs): Platform technologies for diagnostic imaging. Adv Drug Deliv Rev 2006; 58:1505-1522.
22. Wen AM, Lee KL, Yildiz I, Bruckman M.A., Shukla S., Steinmetz NF. Viral nanoparticles for in vivo tumor imaging. J Vis Exp 2012:e4352.
23. Rappaport I. The antigenic structure of Tobacco mosaic virus. Adv Virus Res 1965; 11:223-275.
24. Van Regenmortel MH, Altschuh D, Zeder-Lutz G. Tobacco mosaic virus: A model antigen to study virus-antibody interactions. Biochimie 1993; 75:731-739.
25. Hinrichs J, Berger S, Shaw JG. Induction of antibodies to plant viral proteins by DNA-based immunization. J Virol Methods 1997; 66:195-202.
26. Smith ML, Corbo T, Bernales J., Lindbo JA, Pogue GP, Palmer KE, McCormick AA. Assembly of trans-encapsidated recombinant viral vectors engineered from Tobacco mosaic virus and Semliki Forest virus and their evaluation as immunogens. Virology 2007; 358:321-333.
27. Van Regenmortel MH. The antigenicity of Tobacco mosaic virus. Philos Trans R Soc, B 1999; 354:559-568.
28. Heinz FX, Allison SL, Stiasny K, Schalich J., Holzmann H, Mandl CW, Kunz C. Recombinant and virion-derived soluble and particu-late immunogens for vaccination against tick-borne encephalitis. Vaccine 1995; 13:1636-1642.
29. Smith ML, Lindbo JA, Dillard-Telm S, Brosio P.M., Lasnik AB, McCormick AA, Nguyen LV, Palmer KE. Modified Tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications. Virology 2006; 348:475-488.
30. Staczek J, Bendahmane M, Gilleland L.B., Beachy RN, Gilleland HE, Jr. Immunization with a chimeric Tobacco mosaic virus containing an epitope of outer membrane protein F of Pseudomonas aeruginosa provides protection against challenge with P. aeruginosa. Vaccine 2000; 18:2266-2274.
31. Bruckman MA, Kaur G, Lee L.A., Xie F., Sepulveda J, Breitenkamp R, Zhang X., Joralemon M, Russell TP, Emrick T, Wang Q. Surface modification of Tobacco mosaic virus with "click" chemistry. ChemBioChem 2008; 9:519-523.
32. Pinchuk LM, Filipov NM. Differential effects of age on circulating and splenic leukocyte populations in C57BL/6 and BALB/c male mice. Immun Ageing 2008; 5:1.
33. Veriter S, Mergen J, Goebbels R.M., Aouassar N., Gregoire C, Jordan B, Leveque P., Gallez B, Gianello P, Dufrane D. In vivo selection of biocompatible alginates for islet encapsulation and subcutaneous transplantation. Tissue Eng Part A 2010; 16:1503-1513.
34. Zan X, Sitasuwan P, Powell J., Dreher TW, Wang Q. Polyvalent display of RGD motifs on turnip yellow mosaic virus for enhanced stem cell adhesion and spreading. Acta Biomater 2012; 8:2978-2985.
35. McCormick AA, Palmer KE. Genetically engineered Tobacco mosaic virus as nanoparticle vaccines. Expert Rev Vaccines 2008; 7:33-41.
36. Modelska A, Dietzschold B, Sleysh N., Fu ZF, Steplewski K, Hooper DC, Koprowski H, Yusibov V. Immunization against rabies with plant-derived antigen. Proc Natl Acad Sci USA 1998; 95:2481-2485.
37. Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol 2008; 20:86-100.
38. Eiselt P, Yeh J, Latvala R.K., Shea LD, Mooney DJ. Porous carriers for biomedical applications based on alginate hydrogels. Biomaterials 2000; 21:1921-1927.
39. Nunamaker EA, Purcell EK, Kipke DR. In vivo stability and bio-compatibility of implanted calcium alginate disks. J Biomed Mater Res Part A 2007; 83:1128-1137.
40. VandeVord PJ, Matthew HW, DeSilva S.P., Mayton L., Wu B, Wooley PH. Evaluation of the biocompatibility of a chitosan scaffold in mice. J Biomed Mater Res 2002; 59:585-590.
41. Lee KY, Mooney DJ. Hydrogels for tissue engineering. Chem Rev 2001; 101:1869-1879.
42. Nicodemus GD, Bryant SJ. Cell encapsulation in biodegradable hydrogels for tissue engineering applications. Tissue Eng Part B 2008; 14:149-165.
43. Andersen T, Melvik JE, Gaserod O, Alsberg E., Christensen BE. Ionically gelled alginate foams: physical properties controlled by operational and macromolecular parameters. Biomacromolecules 2012; 13:3703-3710.
44. Augst AD, Kong HJ, Mooney DJ. Alginate hydrogels as biomaterials. Macromol Biosci 2006; 6:623-633.
45. Holme HK, Lindmo K, Kristiansen A., Smidsrod O. Thermal depo-lymerization of alginate in the solid state. Carbohydr Polym 2003; 54:431-438.
46. Nsereko S, Amiji M. Localized delivery of paclitaxel in solid tumors from biodegradable chitin microparticle formulations. Biomaterials 2002; 23:2723-2731.